Back to search
Oligoasthenozoospermia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oligoasthenozoospermia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Oligoasthenozoospermia trials you may qualify forInfertility remains a significant global burden. Estimates suggest that 10-15% of couples worldwide experience infertility, with male infertility being the unde…
The goal of this clinical trial is to learn if drug clomiphene citrate improves sperm parameters in infertile men with idiopathic oligoasthenozoospermia. It wil…
Male infertility is a multifactorial disease process with a number of potential contributive causes. Considering the majority of male infertility cases are due…
The goal of this clinical trial is to compare in Oligozoospermia Patient. The main questions it aims to answer are: 1. Electroacupuncture therapy and standard t…
Male infertility affects millions of males worldwide and is rising in prevalence due to social and environmental conditions. Asthenozoospermia (AZS) and oligoas…
Numerous studies verify that the majority of cases of male infertility belong to the group diagnosed with oligoasthenoteratozoospermia (OAT), which means a decr…